180 Life Sciences Corp.
ATNF
$2.00
$0.010.50%
Headlines
4/12/2024
-
Ticker Report
3/14/2024
-
The Fly
3/14/2024
-
Globe Newswire
3/14/2024
-
Ticker Report
3/2/2024
-
Zolmax
2/28/2024
-
The Fly
2/26/2024
-
The Fly
2/26/2024
-
Globe Newswire
12/26/2023
-
Bizjournals.com - Health Care News
12/23/2023
-
Zolmax
12/4/2023
-
The Fly
12/4/2023
-
Globe Newswire
12/1/2023
-
Zolmax
11/28/2023
-
The Fly
11/28/2023
-
Globe Newswire
10/28/2023
-
Ticker Report
10/15/2023
-
Zolmax
9/13/2023
-
Ticker Report
8/26/2023
-
Ticker Report
8/14/2023
-
Globe Newswire
8/14/2023
-
Ticker Report
8/10/2023
-
Seeking Alpha - Healthcare
8/10/2023
-
Globe Newswire
8/9/2023
-
InvestorPlace
8/9/2023
-
InvestorPlace
Filings
Monday, March 25, 2024
Sunday, December 31, 2023
Week of May 13 and 17 (est)
Price History
Corporate Info
650 507 0669
Building 4
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
--
Business Description
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory...
more